Your gut is a bustling ecosystem, and sometimes its inner workings send out signals in the form of specific proteins and markers. Two of the most talked-about are zonulin and calprotectin. Zonulin is a protein that modulates the openings between cells in your intestinal lining, essentially acting as a gatekeeper for gut permeability [1][10]. Calprotectin, on the other hand, is a protein released by immune cells during inflammation, making it a direct indicator of gut immune activity [1][2].
Understanding these markers can offer valuable insights into your digestive health, from detecting increased intestinal permeability (often called 'leaky gut') to identifying active inflammation. This article breaks down what these biomarkers are, what they can tell you, and how they are being studied in conditions ranging from inflammatory bowel disease to metabolic syndrome [4][10].
Key takeaways
- Zonulin is a key regulator of intestinal permeability, while calprotectin is a direct marker of gut inflammation [1][2].
- Dietary changes, such as increasing (poly)phenol-rich foods or consuming oats, may help lower both zonulin and calprotectin levels [1][10].
- Elevated levels of these markers are linked to a wide range of conditions, from IBD and IBS to metabolic syndrome and Parkinson's disease [4][8][11].
- The gut-brain axis highlights how gut barrier health and inflammation can influence neurological and mental health [15].
- These biomarkers reflect a dynamic interaction between diet, the gut microbiome, and the immune system [9][10].
What is Zonulin and What Does It Tell Us?
Zonulin is the only known physiological modulator of intercellular tight junctions, the 'gates' that control what passes from your gut into your bloodstream [1]. When zonulin levels rise, these gates open wider, a state known as increased intestinal permeability [1]. This can allow partially digested food particles, bacteria, and toxins to cross into the body, potentially triggering an immune response [4].
Research has linked elevated serum zonulin to various conditions. For instance, a study on older adults with increased intestinal permeability used high zonulin levels as a selection criterion [1]. In people with metabolic syndrome, a short-term, calorie-restricted oat diet was associated with a decrease in serum zonulin, which correlated with an increase in beneficial short-chain fatty acids (SCFAs) like butyrate [10]. This suggests that diet can directly influence this gut barrier marker. Zonulin is also studied in conditions like Parkinson's disease, where it is used alongside other markers to assess barrier dysfunction [8].
Calprotectin: A Key Marker of Gut Inflammation
Calprotectin is a protein complex released primarily by neutrophils, a type of white blood cell, during inflammation [2]. It is a well-established marker for intestinal inflammation, and its levels are often measured in stool samples [1][2]. Elevated faecal calprotectin is a strong indicator of active inflammation in the gut, commonly seen in inflammatory bowel disease (IBD) [4].
However, its role extends beyond IBD. A meta-analysis found that faecal calprotectin was significantly elevated in infants with colic, supporting the idea that gut inflammation plays a role in this condition [11]. In a study of patients with radiographic axial spondyloarthritis (a type of arthritis), serum calprotectin levels were higher than in controls and decreased after treatment with TNF inhibitors [2]. Interestingly, a polyphenol-rich diet was shown to significantly reduce both serum and faecal calprotectin in older adults with increased intestinal permeability, suggesting that diet can help lower gut inflammation [1].
How Are These Markers Connected to Gut Health and Disease?
Zonulin and calprotectin often appear together in research as complementary pieces of the gut health puzzle. Zonulin reflects the barrier's integrity, while calprotectin indicates the level of immune activation or inflammation [1][2].
In conditions like IBD, a 'leaky gut' (potentially indicated by high zonulin) can allow more bacterial products to enter the gut wall, fueling the inflammatory cycle that calprotectin measures [4][16]. A systematic review on irritable bowel syndrome (IBS) found that while no single biomarker is diagnostic, markers of immune activation and barrier function are consistently different in IBS patients compared to healthy controls [12]. Furthermore, a study on peritoneal dialysis patients found that calprotectin levels correlated with insulin resistance, highlighting a link between gut inflammation and metabolic health [7].
Can Diet Influence Zonulin and Calprotectin Levels?
Yes, emerging research strongly suggests that dietary choices can modulate these biomarkers. The MaPLE study demonstrated that a diet rich in (poly)phenols (found in fruits, vegetables, tea, and cocoa) significantly reduced both serum and faecal calprotectin in older adults with high intestinal permeability [1].
Similarly, a short-term, high-dose oat diet under calorie restriction was linked to a decrease in serum zonulin, an effect that was associated with positive changes in the gut microbiome and an increase in SCFAs [10]. A diet designed to support a healthy gut microbiota (the Dietary Index for Gut Microbiota, or DI-GM), which emphasizes prebiotic fibers, polyphenols, and fermented foods, was associated with lower systemic inflammation and a reduced risk of colorectal cancer [14]. These findings indicate that a diet rich in plant-based, anti-inflammatory foods may help support a healthy gut barrier and reduce inflammation.
The Bigger Picture: Gut Markers and Overall Health
The implications of gut barrier dysfunction and inflammation extend far beyond the digestive system. The 'gut-brain axis' is a key area of research, with studies linking gut health to neurological and psychiatric conditions [15]. For example, constipation and intestinal barrier dysfunction (marked by zonulin) have been linked to Parkinson's disease [8].
In orthopedic surgery, the composition of the gut microbiome and markers of inflammation can influence recovery, infection rates, and even cognitive function after surgery [3]. A systematic review highlighted that a 'Western diet' can negatively impact the microbiota-gut-brain axis, while a Mediterranean diet may have protective effects [15]. Understanding markers like zonulin and calprotectin is therefore not just about gut health; it's about understanding a central hub that influences your entire body's inflammatory state and overall well-being [4][15].
Frequently asked questions
What is the difference between zonulin and calprotectin?
Zonulin is a protein that regulates the permeability of your intestinal lining, acting like a gatekeeper [1][10]. Calprotectin is a protein released by immune cells during inflammation, serving as a direct marker of gut immune activity [1][2]. In short, zonulin tells you about barrier function, while calprotectin tells you about inflammation.
Can diet really lower my calprotectin levels?
Yes, research suggests it can. A randomized controlled trial found that a diet rich in (poly)phenols significantly reduced both serum and faecal calprotectin in older adults with increased intestinal permeability [1]. This indicates that anti-inflammatory, plant-rich diets may help lower gut inflammation.
Are high zonulin and calprotectin levels only seen in IBD?
No, they are not exclusive to IBD. Elevated levels have been observed in a variety of conditions, including metabolic syndrome [10], infant colic [11], Parkinson's disease [8], and even in some cases of arthritis [2]. They are general markers of gut barrier dysfunction and inflammation, respectively.
How are zonulin and calprotectin measured?
Zonulin is typically measured in a blood sample (serum) [1][10]. Calprotectin can be measured in both blood (serum) and stool (faecal) samples, with faecal calprotectin being the most common and specific marker for intestinal inflammation [1][2][11].
Should I get my zonulin or calprotectin levels tested?
These tests are primarily used in clinical research and for diagnosing and monitoring specific conditions like IBD. If you have persistent digestive symptoms, it is best to discuss appropriate testing with a healthcare provider who can interpret the results in the context of your overall health.
References
- A (poly)phenol-rich diet reduces serum and faecal calprotectin in older adults with increased intestinal permeability: the MaPLE randomised controlled trial — Marino M et al., 2024, BMC geriatrics
- Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritis — Rademacher J et al., 2024, RMD open
- The Role of Gut Microbiota in Orthopedic Surgery: A Systematic Review — Nadeem-Tariq A et al., 2025, Microorganisms
- Pathophysiological Links Between Inflammatory Bowel Disease and Cardiovascular Disease: The Role of Dysbiosis and Emerging Biomarkers — Šantić R et al., 2025, Biomedicines
- Identification of Gut Biomarkers of FPIES in a Longitudinal Comparative Pediatric Study — Lemoine A et al., 2025, Allergy
- First insights into microbial changes within an Inflammatory Bowel Disease Family Cohort study — Rausch P et al., 2025, Gut microbes
- Gut permeability, circulating bacterial fragments and measures of congestion in peritoneal dialysis — Li C et al., 2024, Clinical kidney journal
- Interplay of constipation, intestinal barrier dysfunction and fungal exposome in aetiopathogenesis of Parkinson's disease: hypothesis with supportive data — Umamahesan C et al., 2025, The Biochemical journal
- Host-microbiota interactions in the infant gut revealed by daily faecal sample time series — van Beek N et al., 2025, Microbiome research reports
- Calorie-restricted oat diet is associated with zonulin and short-chain fatty acid response in metabolic syndrome: a randomized controlled trial — Klümpen L et al., 2026, Gut microbes
- The Role of Inflammation in Infant Colic-A Systematic Review and Meta-Analysis — Andersen DB et al., 2026, Acta paediatrica (Oslo, Norway : 1992)
- Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysis — Burns GL et al., 2026, EBioMedicine
- Influence of Nutritional Strategies on Performance, Gut Barrier Function and Microbiota Composition in Weaned Piglets — Isusi S et al., 2025, Animals : an open access journal from MDPI
- Dietary index for gut microbiota is inversely associated with colorectal cancer risk: a case-control study — Song Q et al., 2026, Frontiers in nutrition
- Consequences of Western and Mediterranean Diets' Nutrients on the Microbiota-Gut-Brain Axis — Michel A et al., 2026, Nutrients
- Vitamin D Receptor-Macrophage-IL-23 Axis in Inflammatory Bowel Disease: Pathogenic Mechanisms and Therapeutic Hope — Grigoraș A et al., 2026, Journal of clinical medicine